Locanabio

Locanabio

Locanabio is a San Diego, California-based biotechnology company developing RNA-targeting gene therapies.

Locanabio is a developer of RNA-targeting gene therapies and other precision medicines to treat a range of human genetic diseases.

Timeline

December 2020
Locanabio raises a $100,000,000 series B round from GV, Acuta Capital Partners, Vida Ventures, RA Capital Management, UCB Ventures, SVB Leerink, ARCH Venture Partners, Lightstone Ventures, Invus and Temasek Holdings.
June 12, 2019
Locanabio raises a $550,000 grant from Muscular Dystrophy Association.
May 22, 2019
Locanabio raises a $55,000,000 series A round from GV, UCB Ventures, ARCH Venture Partners, Lightstone Ventures and Temasek Holdings.

Funding rounds

Funding round
Funding type
Funding round amount (USD)
Funding round date
Investment
Locanabio Series B round December 2020
100,000,000
December 2020
3 Results
Results per page:
Page 1 of 1

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.